NCT03377881View on ClinicalTrials.gov

Prostate Cancer Detection Using the Stockholm3 Test and MR/Fusion Biopsies

NAActive, not recruitingINTERVENTIONAL
Enrollment

12,750

Participants

Timeline

Start Date

April 4, 2018

Primary Completion Date

December 10, 2020

Study Completion Date

December 10, 2030

Conditions
Prostate Cancer
Interventions
PROCEDURE

MRI/Fusion biopsies

The intervention in the experimental arm is an MRI with targeted biopsies using fusion technique to prostate lesions. Repeat screening is offered after 2-6 years on an individualised basis.

PROCEDURE

Systematic biopsies

The intervention in the control arm is traditional systematic biopsies of the prostate.

Trial Locations (3)

Unknown

C-medical Odenplan Urology, Stockholm

Capio St Görans Hospital, Stockholm

Urologifocus, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT03377881 - Prostate Cancer Detection Using the Stockholm3 Test and MR/Fusion Biopsies | Biotech Hunter | Biotech Hunter